Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.

Source:http://linkedlifedata.com/resource/pubmed/id/19484631

Download in:

View as

General Info

PMID
19484631